Apolipoprotein E Ε4 Allele and Malondialdehyde Level Are Independent Risk Factors for Alzheimer’s Disease

SAGE Open Medicine - United Kingdom
doi 10.1177/2050312115626731
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

SAGE Publications

Related search

Apolipoprotein E Ɛ4 Allele Increases Risk for Psychotic Symptoms in Alzheimer's Disease

Neuropsychopharmacology
PsychiatryMental HealthPharmacology
2006English

Risk Factors for Alzheimer’s Disease

Science Insights
2020English

Absence of an Apolipoprotein E Ε4 Allele Is Associated With Increased Parietal Regional Cerebral Blood Flow Asymmetry in Alzheimer Disease

Archives of Neurology
1998English

Common BACE2 Polymorphisms Are Associated With Altered Risk for Alzheimer’s Disease and CSF Amyloid Biomarkers in APOE Ε4 Non-Carriers

Scientific Reports
Multidisciplinary
2019English

Apolipoprotein E Alleles as Risk Factors in Alzheimer's Disease

Annual Review of Medicine
BiochemistryMedicineGeneticsMolecular Biology
1996English

Hypometabolism in Alzheimer-Affected Brain Regions in Cognitively Healthy Latino Individuals Carrying the Apolipoprotein E Ε4 Allele

Archives of Neurology
2010English

Depressive Symptoms in Healthy Apolipoprotein E Ε4 Carriers and Noncarriers

Journal of Clinical Psychiatry
MedicinePsychiatryMental Health
2013English

The MAPT H1 Haplotype Is a Risk Factor for Alzheimer’s Disease in APOE Ε4 Non-Carriers

Frontiers in Aging Neuroscience
AgingCognitive Neuroscience
2019English

Environmental Factors Influencing the Link Between APOE Ε4 and Alzheimer's Disease (AD) Risk

International Psychogeriatrics
PsychiatryClinical PsychologyGerontologyGeriatricsMental Health
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy